Treatment of Microscopic Colitis
- Registration Number
- NCT00184171
- Lead Sponsor
- Norwegian University of Science and Technology
- Brief Summary
The study compares the effect of Budesonide, Bismuth and fiber in patients with microscopic colitis
- Detailed Description
This randomized, controlled, open study compares the effects of 8 weeks' treatment with Budesonide, Bismuth and fiber on symptoms and histological findings in patients with microscopic colitis (both collagenous colitis and lymphocytic colitis).
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 105
- Microscopic colitis verified with biopsies from the colon
- Symptoms to such an extent that treatment is indicated
- Age > 17 years
- Informed consent
- Previous treatment with any of the investigational drugs
- Patients treated with ketoconazole
- Pregnant and breast-feeding females
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description bismuth Bismuth Bismuth mixture Fiber Fiber Fiber preparation Budesonide Budesonide Budesonide 9mg
- Primary Outcome Measures
Name Time Method Symptoms: Stool frequency and consistency 2001 - 2011 September 2010: Patient's enrollment completed. Data analysis ongoing.
- Secondary Outcome Measures
Name Time Method Histological findings in biopsies from colon 2001 - 2011 Patient's enrollment completed. Data analysis ongoing.
Trial Locations
- Locations (9)
Aker sykehus
🇳🇴Oslo, Norway
Helse NordMøre og Romsdal
🇳🇴Molde, Norway
Sykehuset Innlandet HF, Lillehammer
🇳🇴Lillehammer, Norway
Aust-Agder Sentralsjukehus
🇳🇴Arendal, Norway
Sykehuset Innlandet, HF, Hamar
🇳🇴Hamar, Norway
Rikshopitalet
🇳🇴Oslo, Norway
Sykehuset Innlandet HF, Gjøvik
🇳🇴Gjovik, Norway
Akershus Universitetssykehus
🇳🇴Nordbyhagen, Norway
St. Olavs Hospital
🇳🇴Trondheim, Norway